Zentalis Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (ZNTL)

172 filings reported holding ZNTL - Zentalis Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share as of Q3 2024.
Zentalis Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (ZNTL) has 133 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 70,964,067 shares of 75,602,672 outstanding shares and own 94% of the company stock.
Largest 10 shareholders include Matrix Capital Management Company, LP (13,959,973 shares), EVENTIDE ASSET MANAGEMENT, LLC (8,547,896 shares), FMR LLC (5,075,837 shares), BlackRock, Inc. (4,761,173 shares), VANGUARD GROUP INC (4,612,707 shares), Decheng Capital LLC (3,108,095 shares), CITADEL ADVISORS LLC (2,717,521 shares), MORGAN STANLEY (1,611,567 shares), Verition Fund Management LLC (1,504,320 shares), and PRIMECAP MANAGEMENT CO/CA/ (1,498,030 shares).
This table shows the top 133 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.